{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Slice of Healthcare","title":"#230 - Nancy Lurker, CEO at EyePoint Pharmaceuticals","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/921d162d\"></iframe>","width":"100%","height":180,"duration":891,"description":"In this episode, Nancy Lurker, CEO at EyePoint Pharmaceuticals, joins to discuss her background, overview of EyePoint Pharmaceuticals\r\nStatus of products in pipeline, how to successfully run a publicly traded small biopharma company with happy patients and investors, \r\nthe difference from running a large vs. smaller pharma company, and suggestions for women CEO’s taking a similar approach or rising STEM majors on how best to navigate their career path.","thumbnail_url":"https://img.transistorcdn.com/lJie6yFJ7wjX-ul1e8Pfq2LhudMIbOYsSY7IsHDGxKs/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zOGU1/NDMyNjljYmQxMDY2/MzM5NzEyZTI5NmU3/MWNiOS5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}